Friday, February 21, 2020, 8:00 AM - 3:30 PM, The Bradley Lecture Center, Birmingham, AL


With rare diseases being common in primary care, an avenue is needed for professionals to achieve the same confidence in treating patients with co-morbid rare diseases that they have when treating the general population.  Rare disease knowledge and awareness are the lowest among primary care physicians and highest among specialists.

1. Summarize the latest genomic discoveries and technology innovations driving rare disease research and precision medicine.
2. Discuss approaches for applying genomics and bioinformatics to rare disease molecular diagnosis.
3. Identify key barriers to connecting patients and providers with genetic counselors and keeping them engaged.
4. Review deep phenotyping software for clinical genetics evaluation.
5. Discuss practical strategies for integrating software into clinic.
6. Review emerging trends how deep learning and bioinformatics strategies can be combined to bring new hopes for devising cost-effective solutions to treat rare human genetic disorders.
7. Discuss how AI can help with therapeutic identification in precision medicine.

Children's of Alabama designates this Live Activity for a maximum of 5.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Children’s of Alabama is accredited by the Medical Association of the State of Alabama to provide continuing medical education for physicians.

AMA PRA Category 1 Credits™ (5.25 hours), Non-Physician Attendance (5.25 hours)

The registration form for this activity is currently unavailable.

Friday, February 21, 2020

There is no Commercial Support associated with this activity.